Vaxcyte Inc logo

Vaxcyte Inc

NAS:PCVX (USA)  
$ 50.40 +0.045 (+0.09%) 12:19 PM EST
P/E:
At Loss
P/B:
3.30
Market Cap:
$ 4.73B
Enterprise V:
$ 3.45B
Volume:
241.16K
Avg Vol (2M):
495.66K
Also Trade In:
Volume:
241.16K
Market Cap $:
4.73B
PE Ratio:
At Loss
Avg Vol (2M):
495.66K
Enterprise Value $:
3.45B
PB Ratio:
3.30

Business Description

Description
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-XP, VAX-A1, and VAX-PG.
Name Current Vs Industry Vs History
Cash-To-Debt 84.63
Equity-to-Asset 0.95
Debt-to-Equity 0.01
Debt-to-EBITDA -0.06
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -19.9
3-Year EPS without NRI Growth Rate -10.4
3-Year FCF Growth Rate -12.9
Name Current Vs Industry Vs History
5-Day RSI 35.03
9-Day RSI 44.22
14-Day RSI 48.58
6-1 Month Momentum % 28.73
12-1 Month Momentum % 94.91

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 21.76
Quick Ratio 21.76
Cash Ratio 21.37

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -19.3
Shareholder Yield % -46.6
Name Current Vs Industry Vs History
ROE % -32.63
ROA % -30.5
ROIC % -247.7
ROC (Joel Greenblatt) % -815.55
ROCE % -33.37

Financials (Next Earnings Date:2023-11-07 Est.)

PCVX's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PCVX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Vaxcyte Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -3.35
Beta 0.67
Volatility % 85.94
14-Day RSI 48.58
14-Day ATR ($) 1.617831
20-Day SMA ($) 51.30825
12-1 Month Momentum % 94.91
52-Week Range ($) 20.49 - 54.97
Shares Outstanding (Mil) 93.85

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Vaxcyte Inc Filings

Filing Date Document Date Form
No Filing Data

Vaxcyte Inc Stock Events

Event Date Price($)
No Event Data

Vaxcyte Inc Frequently Asked Questions

What is Vaxcyte Inc(PCVX)'s stock price today?
The current price of PCVX is $50.40. The 52 week high of PCVX is $54.97 and 52 week low is $20.49.
When is next earnings date of Vaxcyte Inc(PCVX)?
The next earnings date of Vaxcyte Inc(PCVX) is 2023-11-07 Est..
Does Vaxcyte Inc(PCVX) pay dividends? If so, how much?
Vaxcyte Inc(PCVX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1